Skip to content

Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI

Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00721929
Enrollment
16
Registered
2008-07-25
Start date
2003-10-31
Completion date
2012-07-31
Last updated
2012-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenal Gland Disease

Keywords

adrenal glands, adrenal masses

Brief summary

The purpose of this study is to determine if certain MRI sequences can accurately diagnose adrenal masses of unknown origin.

Interventions

PROCEDUREMRI

Magnetic Resonance Imaging

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients can participate in this study if they are 18 years of age or older and if they have had a Cat Scan (CT scan) performed with and without contrast media (medication given intravenously to enhance the CT images) or if patients are scheduled to have a CT scan performed and if the reason their physician ordered the CT is because they have an adrenal mass of an unknown type.

Exclusion criteria

* Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator. * Pregnant patients or patients who are lactating. * A patient who is claustrophobic and would require sedation to complete the MRI exam.

Design outcomes

Primary

MeasureTime frameDescription
Diagnosis of either benign or malignant adrenal mass on pathology0-6 monthsdefinitive diagnosis of adrenal mass

Secondary

MeasureTime frameDescription
stability of growth of mass on follow up imaging3-24 monthsevidence for benign or malignant mass based on assessment of stability or growth

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026